<DOC>
	<DOCNO>NCT00150553</DOCNO>
	<brief_summary>The purpose study compare efficacy safety SPD417 treat bipolar manic symptom , give daily even vs. twice daily .</brief_summary>
	<brief_title>Efficacy Safety SPD417 Treatment Manic Symptoms Adults With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>DSMIV criterion bipolar I disorder Screen YMRS score = &gt; 16 Women childbearing potential agree take adequate precaution contraception Hospitalization require treatment psychiatric symptom Patients meet DSMIV ultrarapid cycle History serious suicide attempt require medical intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
</DOC>